Research Paper Volume 15, Issue 11 pp 4963—4985
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
Figure 5. Correlation of FDX1 expression with immune status. (A–D) Association between FDX1 expression and ESTIMATE, stromal, and immune scores and tumor purity. (E, F) Immune cell infiltration levels and immune-related function in high- and low-FDX1 expression groups. (G) Differences in expression of immune checkpoint genes between high- and low- FDX1 expression groups. (H) Correlation between FDX1 and immune subtypes.